|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS; THESE EFFECT MAY BE PRONOUNCED IN THE ELDERLY
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
HEPARIN ACTIVITY IS REDUCED BY THE DRUG
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
HYALURONIDASE EFFECT IS INHIBITED BY THE DRUG
|
PATIENTS ON ANTICOAGULATION THERAPY ARE AT RISK FOR BLEEDING
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
HEPARIN ACTIVITY IS REDUCED BY THE DRUG
|
HEPARIN ACTIVITY IS REDUCED BY THE DRUG
|
HEPARIN ACTIVITY IS REDUCED BY THE DRUG
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS; THESE EFFECT MAY BE PRONOUNCED IN THE ELDERLY
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS; THESE EFFECT MAY BE PRONOUNCED IN THE ELDERLY
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
HEPARIN ACTIVITY IS REDUCED BY THE DRUG
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
HEPARIN ACTIVITY IS REDUCED BY THE DRUG
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS; THESE EFFECT MAY BE PRONOUNCED IN THE ELDERLY
|
CO-ADMINISTRATION HAS RESULTED IN BLEEDING AND/OR INCREASED PROTHROMBIN TIME IN FEW PATIENTS
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
HEPARIN ACTIVITY IS REDUCED BY THE DRUG
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS; THESE EFFECT MAY BE PRONOUNCED IN THE ELDERLY
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS; THESE EFFECT MAY BE PRONOUNCED IN THE ELDERLY
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
CO-ADMINISTRATION MAY BE ASSOCIATED WITH INCREASED RISK OF BLEEDING
|
PATIENTS ON ANTICOAGULATION THERAPY ARE AT RISK FOR BLEEDING
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
HEPARIN ACTIVITY IS REDUCED BY THE DRUG
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS; THESE EFFECT MAY BE PRONOUNCED IN THE ELDERLY
|
NSAIDS CONCURRENT ADMINISTRATION MAY INCREASE THE RISK OF HAEMORRHAGE
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED ANTICOAGULANT EFFECTS; THESE EFFECT MAY BE PRONOUNCED IN THE ELDERLY
|
ANTICOAGULANT EFFECT IS INCREASED
|